TARS filings
Corporate insider profile
Jeffrey S Farrow Filing Activity
Latest reported as See Remarks of Tarsus Pharmaceuticals, Inc. (TARS).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$877,436.20
- Latest transaction
- Jun 16, 2026
Affiliated corporations
Reported company relationships
Transaction history
